CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 462 enrolled
Drug / intervention
Patients receiving cancer pain treatmentother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02664987
NCT02664987N/ACompleted

A Cross-sectional Study to Investigate the Pain Control Status in Cancer Patients in South East Asian Countries

Mundipharma Pte Ltd.·observational·Posted Jan 27, 2016·Updated Oct 31, 2016

In Brief

An observational study evaluating Patients receiving cancer pain treatment for Pain. Completed, enrolled 462 participants.

Detailed Summary

This study is planned to investigate the pain control status in cancer patients in 6 South East Asian countries through evaluation of prescription pattern of analgesics, satisfaction of pain control, quality of life and assessment of the adequacy of pain control and relationship among these factors in cancer patients with pain. Cancer pain is undermanaged and it is hoped that this study will be used as a reference for effective cancer pain management in these countries.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPain
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 27, 2016
Enrollment StartSep 1, 2015
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 10.4 years ago

Interventions

Patients receiving cancer pain treatmentother